Company profile: SmartPill
1.1 - Company Overview
Company description
- Provider of ingestible, capsule-based medical devices that aid in the diagnosis, definition, and therapeutic intervention of gastrointestinal disorders and diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SmartPill
Neurogastrx
HQ: United States
Website
- Description: Provider of biopharmaceutical drug development, focusing on NG101, an oral small molecule dopamine D2 receptor antagonist for the treatment of gastroparesis, which has completed a Phase 2 clinical trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurogastrx company profile →
Echosens
HQ: France
Website
- Description: Provider of non-invasive hepatology diagnostics, offering FibroScan devices for assessment of liver fibrosis and steatosis, including Next-Generation FibroScan, FibroScan 630 Expert for liver/spleen stiffness and ultrasound attenuation, and portable FibroScan Compact 530. Solutions include LSM by VCTE for fibrosis and CAP for steatosis, supported by extensive peer-reviewed publications and international guidelines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Echosens company profile →
Integrated Endoscopy
HQ: United States
Website
- Description: Provider of single-use arthroscopes, wireless camera systems, battery-powered shaver systems, arthroscopy pumps, and an integrated NUVIS surgical stack for arthroscopic procedures, offering high-definition optics, clear imaging, reduced setup time, optimized flow, and enhanced efficiency while addressing infection risk and maintenance costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrated Endoscopy company profile →
Innovate Biopharma
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology drug candidates for gastroenterological and orphan disorders: INN-202 (Phase 3, celiac disease), INN-329 (Phase 3, enhances pancreatic duct visualization in MRCP diagnostics), INN-108 (Phase 2, mild to moderate ulcerative colitis and other inflammatory bowel disorders), INN-217 (Phase 1/2, nonalcoholic steatohepatitis), and INN-289 (Phase 1, subset of Crohn’s disease).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Innovate Biopharma company profile →
EndoChoice
HQ: United States
Website
- Description: Provider of platform technologies for treating gastrointestinal (GI) diseases, offering devices, diagnostics, infection control solutions, and endoscopic imaging for specialists; leverages a direct sales organization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EndoChoice company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SmartPill
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SmartPill
2.2 - Growth funds investing in similar companies to SmartPill
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SmartPill
4.2 - Public trading comparable groups for SmartPill
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →